Suraksha Diagnostic Limited (BOM:544293)

Suraksha Diagnostic Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Net Income	236.26	65.16	208.24	64.35
Depreciation & Amortization	321.96	313.06	278.13	147.46
Other Amortization	4.02	3.65	5.82	9.66
Loss (Gain) From Sale of Assets	21.45	24.33	14.15	24.5
Asset Writedown & Restructuring Costs	7.79	-	-	-
Loss (Gain) From Sale of Investments	-	-	-	-2.94
Provision & Write-off of Bad Debts	5.36	-	0.72	28.44
Other Operating Activities	44.87	-13.53	107.01	-9.53
Change in Accounts Receivable	-47.29	24.82	-15.71	-28.44
Change in Inventory	-5.16	0.63	-17.81	10.01
Change in Accounts Payable	3.54	4.81	16.51	-3.31
Change in Other Net Operating Assets	12.04	18.03	-18.83	-5.09
Operating Cash Flow	604.84	440.96	578.23	235.12
Operating Cash Flow Growth	37.16%	-23.74%	145.93%	-
Capital Expenditures	-446.94	-131.67	-192.49	-154.01
Sale of Property, Plant & Equipment	17.73	6.61	3.44	2.5
Cash Acquisitions	-	-	-	-33.6
Investment in Securities	47.35	-108.26	-260.93	-98.09
Other Investing Activities	31.9	25.37	17.17	6.11
Investing Cash Flow	-349.96	-207.95	-432.81	-277.08
Long-Term Debt Issued	5	20.5	95.91	48.31
Long-Term Debt Repaid	-254.25	-250.82	-223.74	-
Net Debt Issued (Repaid)	-249.25	-230.32	-127.83	48.31
Other Financing Activities	-2.05	-12.96	-15.02	-16.2
Financing Cash Flow	-251.3	-243.28	-142.85	32.11
Net Cash Flow	3.58	-10.27	2.57	-9.86
Free Cash Flow	157.9	309.29	385.74	81.11
Free Cash Flow Growth	-48.95%	-19.82%	375.57%	-
Free Cash Flow Margin	7.22%	16.27%	17.28%	5.79%
Free Cash Flow Per Share	2.96	5.80	7.24	1.52
Cash Interest Paid	9.08	12.96	15.02	16.2
Cash Income Tax Paid	86.1	71.93	27.96	15.03
Levered Free Cash Flow	53.51	270.18	287.95	-
Unlevered Free Cash Flow	108.44	326.8	343.23	-
Change in Net Working Capital	18.19	-49.97	-28.66	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.